rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    NRIX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Nurix at UBS Global Biopharma Conference 2026: Roche deal lifts stakes
      Nov 17Investing.comNRIXUBS
      Nurix Therapeutics appoints Arati Rao as chief medical officer
      Nov 11Investing.comNRIX
      Nurix Therapeutics to Participate in Upcoming Investor Conferences
      Nov 10Yahoo FinanceNRIX
      Is Early B Cell Cancer Data Altering The Investment Case For Nurix Therapeutics (NRIX)?
      Nov 7Yahoo FinanceNRIX
      Nurix to present bexobrutideg data at ASH meeting
      Nov 5Investing.comNRIX
      Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition
      Nov 5Yahoo FinanceNRIX
      Cathie Wood’s ARK sells SpaceX stock, buys Nurix Therapeutics
      Nov 5Investing.comNRIXSPCX
      Nurix CFO Hans van Houte sells $74,562 in shares
      Nov 4Investing.comNRIX
      Sanofi Breaks Out; Why Its Eczema Partner Just Crashed

      Its partner is a highly rated biotech stock that was forming a consolidation ahead of the news.

      Nov 4Investor's Business DailyNRIXSNY
      Nurix Therapeutics Shares Plunge 28.4% as Sanofi Terminates STAT6 Drug Development Programme
      Nov 4Yahoo FinanceNRIXSNY
      Nurix stock falls as Sanofi scraps partnered drug (NRIX:NASDAQ)

      Nurix Therapeutics (NRIX) stock falls as Sanofi (SNY) ends its inflammatory disease drug program. Read more here.

      Nov 4Seeking AlphaNRIXSNY
      Why is Nurix Therapeutics stock collapsing 28% today?
      Nov 4Investing.comNRIX
      Jefferies cuts Nurix stock price target on partner’s program halt
      Nov 4Investing.comNRIX
      NRIX Slumps 35% After-Hours — What’s Driving The Selloff?
      Nov 3Yahoo FinanceNRIX
      Nurix says Sanofi discontinues autoimmune disease drug program
      Nov 3ReutersNRIXSNY
      Nurix Therapeutics stock tumbles on Sanofi program termination
      Nov 3Investing.comNRIX
      Sanofi discontinues Nurix drug trial, terminates program
      Nov 3Investing.comNRIXSNY
      Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
      Nov 3Yahoo FinanceNRIXSNY
      Nurix Therapeutics CFO Hans van Houte sells $74,474 of stock
      Nov 3Investing.comNRIX
      Nurix Therapeutics chief legal officer sells $103,986 in shares
      Nov 3Investing.comNRIX
      Nurix Therapeutics CSO Gwenn Hansen sells $142,899 in stock
      Nov 3Investing.comNRIX
      What Nurix Therapeutics Stock's Profit Turnaround Means For Shareholders
      Oct 22Yahoo FinanceNRIX
      H.C. Wainwright raises Nurix stock price target on strong revenue
      Oct 16Investing.comNRIX
      Nurix Therapeutics CSO Gwenn Hansen sells $36,300 in common stock
      Oct 16Investing.comNRIX
      Nurix Therapeutics’ High-Stakes Reliance on Roche: Cost Burdens, Control Risks and Uncertain Returns for Lead Drug Bexobrutideg

      Detailed price information for Nurix Therapeutics Inc (NRIX-Q) from The Globe and Mail including charting and trades.

      Oct 15The Globe and MailNRIX
      Nurix director Gregory sells $528,528 in stock following option exercise
      Oct 15Investing.comNRIX
      Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing
      Oct 14Yahoo FinanceNRIX
      Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways
      Oct 14Seeking AlphaNRIX
      Truist Financial Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)

      Detailed price information for Nurix Therapeutics Inc (NRIX-Q) from The Globe and Mail including charting and trades.

      Oct 14The Globe and MailNRIX
      Nurix Therapeutics: Bexobrutideg Advancing Together With Roche, Kymera’s STAT6 Degrader Data Coming Up
      Oct 13Seeking AlphaKYMRNRIX
      Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says
      Oct 13Yahoo FinanceNRIX
      Stifel raises Nurix stock price target to $41 on Roche deal
      Oct 13Investing.comNRIX
      Truist cuts Nurix stock price target to $33 on model adjustments
      Oct 13Investing.comNRIX
      RBC Capital cuts Nurix stock price target on revised estimates
      Oct 13Investing.comNRIX
      Oppenheimer Adjusts Price Target on Nurix Therapeutics to $32 From $28, Maintains Outperform Rating
      Oct 13Yahoo FinanceNRIX
      RBC Trims Price Target on Nurix Therapeutics to $35 From $36, Keeps Outperform, Speculative Risk
      Oct 13Yahoo FinanceNRIX
      Nurix Therapeutics CLO sells $134k in stock after option exercise
      Oct 13Investing.comNRIX
      Nurix earnings beat by $5.34, revenue topped estimates
      Oct 12Investing.comNRIX
      Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
      Oct 12Investing.comNRIX
      Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates
      Oct 12Yahoo FinanceNRIX
      Nurix Therapeutics Fiscal Q3 Swings to Profit, Revenue Rises; Shares Gain After Hours
      Oct 12Yahoo FinanceNRIX
      Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
      Oct 12Yahoo FinanceNRIX
      Nurix Therapeutics earnings in spotlight amid pipeline gains
      Oct 8Investing.comNRIX
      Is Extending the Gilead E3 Ligase Collaboration Altering The Investment Case For Nurix Therapeutics (NRIX)?
      Oct 7Yahoo FinanceNRIX
      Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia
      Oct 7Yahoo FinanceNRIX
      Nurix enrolls first patient in bexobrutideg combination trial
      Oct 7Investing.comNRIX
      Nurix Therapeutics, Gilead Sciences Agree on Two-Year Research Term Extension for Oncology Program
      Oct 5Yahoo FinanceNRIX
      Nurix receives $7m milestone payment from Pfizer collaboration
      Sep 29Investing.comNRIX
      Nurix Therapeutics to Receive $7 Million Pfizer Collaboration Milestone Payment

      Nurix Therapeutics (NRIX) said Tuesday that it will receive a $7 million milestone payment from Pfiz

      Sep 29Yahoo FinanceNRIX
      Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer
      Sep 29Yahoo FinanceNRIXPFE

      This is the newest page. Registered accounts read further back.